Mindfulness-Based Relapse Prevention to Improve Medication Assisted Treatment Adherence and Drug-use Outcomes for Opioid Use Disorder
Mindful MAT Adherence: Mindfulness-Based Relapse Prevention (MBRP) to Improve Extended-release Naltrexone (XR-NTX) Adherence and Drug-use Outcomes for Opioid Use Disorder (OUD)
Sponsor: National Institute on Drug Abuse (NIDA)
This NA trial investigates Opioid-use Disorder and is currently completed. National Institute on Drug Abuse (NIDA) leads this study, which shows 6 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Jan 2025 — Present [monthly]
Completed NA
Status: Recruiting → Completed
-
Sep 2024 — Jan 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Jan 2024 — Jul 2024 [monthly]
Recruiting NA
Status: Unknown Status → Recruiting
-
Oct 2023 — Jan 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
▶ Show 1 earlier version
-
Oct 2021 — Oct 2023 [monthly]
Recruiting NA
First recorded
Aug 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute on Drug Abuse (NIDA)
- West Chester University of Pennsylvania
For direct contact, visit the study record on ClinicalTrials.gov .